GLAXOSMITHKLINE US TRADING LIMITED

Active London

Wholesale of pharmaceutical goods

0 employees website.com
Wholesale of pharmaceutical goods
G

GLAXOSMITHKLINE US TRADING LIMITED

Wholesale of pharmaceutical goods

Founded 12 Sept 2018 Active London, United Kingdom 0 employees website.com
Wholesale of pharmaceutical goods
Accounts Due 30 Sept 2026 4 months remaining
Confirmation Submitted 29 Sept 2025 Next due 13 Oct 2026 5 months remaining
Net assets £27M £7M 2024 year on year
Total assets £192M £45M 2024 year on year
Total Liabilities £165M £39M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Full company profile for GLAXOSMITHKLINE US TRADING LIMITED (11566030), an active company based in London, United Kingdom. Incorporated 12 Sept 2018. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2019–2024)

Cash in Bank

N/A

Decreased by £1.47M (-100%)

Net Assets

£27.05M

Increased by £6.57M (+32%)

Total Liabilities

£165.02M

Increased by £38.60M (+31%)

Turnover

£815.43M

Increased by £239.92M (+42%)

Employees

N/A

Debt Ratio

86%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Glaxo Group Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Glaxo Group Limited

United Kingdom

Active
Notified 12 Sept 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GSK PLC united kingdom
GLAXO GROUP LIMITED united kingdom
GLAXOSMITHKLINE US TRADING LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
6 Jan 2026AddressChange Registered Office Address Company With Date Old Address New Address
6 Jan 2026InsolvencyLiquidation Voluntary Appointment Of Liquidator
6 Jan 2026ResolutionResolutions
6 Jan 2026InsolvencyLiquidation Voluntary Declaration Of Solvency
10 Nov 2025InsolvencySolvency Statement dated 05/11/25
6 Jan 2026 Address

Change Registered Office Address Company With Date Old Address New Address

6 Jan 2026 Insolvency

Liquidation Voluntary Appointment Of Liquidator

6 Jan 2026 Resolution

Resolutions

6 Jan 2026 Insolvency

Liquidation Voluntary Declaration Of Solvency

10 Nov 2025 Insolvency

Solvency Statement dated 05/11/25

Recent Activity

Latest Activity

Change Registered Office Address Company With Date Old Address New Address

4 months ago on 6 Jan 2026

Liquidation Voluntary Appointment Of Liquidator

4 months ago on 6 Jan 2026

Resolutions

4 months ago on 6 Jan 2026

Liquidation Voluntary Declaration Of Solvency

4 months ago on 6 Jan 2026

Solvency Statement dated 05/11/25

6 months ago on 10 Nov 2025